Statistical and SVM-based oncogene detection of human cDNA expressions for ovarian carcinoma

International Journal of Innovative Computing, Information and Control

Volumn 5, Issue 10, 2009, Pages 3157-3177

  Lai, Ching Hao ^a   Yu, Shyr Shen ^a   Chang, Jun Dong ^a   Tsai, Meng Hsiun ^a  

^a NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

Author keywords

Gene expression analysis; Microarray database; Oncogenes; Ovarian cancer; Support vector machine

Indexed keywords

CROSS VALIDATION; GENE EXPRESSION ANALYSIS; MICROARRAY DATABASE; ONCOGENES; OVARIAN CANCER; OVARIAN CANCERS; OVARIAN CARCINOMA; OVARIAN TUMOR; SCIENTIFIC LITERATURE; STATISTICAL SYSTEMS;

BIOACTIVITY; DATABASE SYSTEMS; GENE EXPRESSION; GRAPHICAL USER INTERFACES; IMAGE RETRIEVAL; MULTILAYER NEURAL NETWORKS; ONCOGENIC VIRUSES; REGRESSION ANALYSIS; SUPPORT VECTOR MACHINES;

ANALYSIS OF VARIANCE (ANOVA);

EID: 70350515475     PISSN: 13494198     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (93)

1. A. Jemal, A. Thomas, T. Murray, and M. Thun, Cancer statistics, CA. Cancer J. Clin., vol. 52, no. 2, pp. 23-47, 2002.
2. G.-S. Huang, Y.-C. Hung, A. Chen, and M.-Y. Hong, Microarray analysis of ovarian cancer, Proc. of the 2005 IEEE International Conference on Systems, Man and Cybernetics, vol. 2, pp. 1036-1041, 2005.
3. M. Schummer, W. V. Ng, R. E. Bumgarner, P. S. Nelson, B. Schummer, D. W. Bednarski, L. Hassell, R. L. Baldwin, B. Y. Karlan, and L. Hood, Comparative hybridization of an array of 21, 500 ovarian cDNAs for the discovery of genes overexpressed in ovarian carcinomas, Gene, vol. 238, no. 2, pp. 375-385, 1999.
4. K. Wang, L. Gan, E. Jeffery, M. Gayle, A. M. Gown, M. Skelly, P. S. Nelson, W. V. Ng, M. Schummer, L. Hood, and J. Mulligan, Monitoring gene expression profile changes in ovarian carcinomas using cDNA microarray, Gene, vol. 229, no. 1-2, pp. 101-108, 1999.
5. R. S. Ismail, R. L. Baldwin, J. Fang, D. Browning, B. Y. Karlan, J. C. Gasson, and D. D. Chang, Differential gene expression between normal and tumor-derived ovarian epithelial cells, Cancer Res., vol. 60, pp. 6744-6749, 2000.
6. A. M. Martoglio, B. D. Tom, M. Starkey, A. N. Corps, D. S. Charnock-Jones, and S. K. Smith, Changes in tumorigenesis-and angiogenesis-related gene transcript abundance profiles in ovarian cancer de-tected by tailored high density cDNA arrays, Mol. Med., vol. 6, no. 9, pp. 750-765, 2000.
7. K. Ono, T. Tanaka, T. Tsunoda, O. Kitahara, C. Kihara, A. Okamoto, K. Ochiai, T. Takagi, and Y. Nakamura, Identification by cDNA microarray of genes involved in ovarian carcinogenesis, Cancer-Res., vol. 60, pp. 5007-5011, 2000.
8. J. B. Welsh, P. P. Zarrinkar, L. M. Sapinoso, S. G. Kern, C. A. Behling, B. J. Monk, D. J. Lockhart, R. A. Burger, G. M. Hampton, Analysis of gene expression profiles in normal and neoplastic ovarian tissue samples identifies candidate molecular markers of epithelial ovarian cancer, Proc. Natl. Acad. Set. USA, vol. 98, no. 3, pp. 1176-1181, 2001.
9. M. Schena, D. Shalon, R. W. Davis, and P. O. Brown, Quantitative monitoring of gene expression patterns with a complementary DNA microarray, Science, vol. 270, no. 5235, pp. 467-470, 1995.
10. A. A. Alizadeh, M. B. Eisen, and R. E. Davis et al., Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling, Nature, vol. 403, no. 6769, pp. 503-511, 2000.
11. J. DeRisi, L. Penland, P. O. Brown, M. L. Bittner, P. S. Meltzer, M. Ray, Y. Chen, Y. A. Su, and J. M. Trent, Use of a cDNA microarray to analyze gene expression patterns in human cancer, Nat. Genet, vol. 14, no. 4, pp. 457-460, 1996.
12. C. H. Lai, J. D. Chang and M. H. Tsai, Hierarchical clustering analysis in diffuse large B-Cell lymphoma microarray database, Proceedings of the 9th Joint Conference on Information Sciences, pp. 693-696, 2006.
13. M. H. Tsai, C. H. Lai, S. J. Lu, and S. F. Su, Performance comparisons between unsupervised clustering techniques for microarray data analysis on ovarian cancer, IEEE Conference on Systems, Man, and Cybernetics, pp. 3685-3690, 2006.
14. M. H. Tsai, C. H. Cheng, and C. H. Lai, A modified fuzzy C-mean scheme for analyzing the diffuse large B-cell lymphoma microarray datasets, GESTS International Transactions on Computer Science and Engineering, vol. 34, no. 1, pp. 179-190, 2006.
15. C. H. Lai, C. H. Cheng, and M. H. Tsai, Analysis of microarray datasets by using self organizing map method, GESTS International Transactions on Computer Science and Engineering, vol. 36, no. 1, pp. 65-76, 2007.
16. V. Vapnik, The Nature of Statistical Learning Theory, Springer-Verlag, New York, 1995.
17. V. Vapnik, Statistical Learning Theory, John Wiley, New York, 1998.
18. Q. She, H. Su, L. Dong and J. Chu, Support vector machine with adaptive parameters in image coding, Int. J. Innovative Computing, Information and Control, vol. 4, no. 2, pp. 359-368, 2008.
19. R. Chen and S. Chen, Intrusion detection using a hybrid support vector machine based on entropy and TF-IDF, Int. J. Innovative Computing, Information and Control, vol. 4, no. 2, pp. 413-424, 2008.
20. X. Song, W. Chen, and B. Jiang, Sample reducing method in support vector machine based on K-closest sub-clusters, Int. J. Innovative Computing, Information and Control, vol. 4, no. 7, pp. 1751-1760, 2008.
21. L. Li, L. Chen, D. Goldgof, F. George, Z. Chen, A. Rao, J. Cragun, R. Sutphen, and J. M. Lancaster, Integration of clinical information and gene expression profiles for prediction of chemo-response for ovarian cancer, Proc. of the 27th Annual International Conference of the Engineering in Medicine and Biology Society, pp. 4818-4821, 2005.
22. J.-T. Jeng, T.-T. Lee, and Y.-C. Lee, Classification of ovarian cancer based on intelligent systems with microarray data, IEEE International Conference on Systems, Man and Cybernetics, vol. 2, pp. 1053-1058, 2005.
23. K. H. Lu, A. P. Patterson, L. Wang, R. T. Marquez, E. N. Atkinson, K. A. Baggerly, L. R. Ramoth, D. G. Rosen, J. Liu, I. Hellstrom, D. Smith, L. Hartmann, D. Fishman, A. Berchuck, R. Schmandt, R. Whitaker, D. M. Gershenson, G. B. Mills, and R. C. J. Bast, Selection of potential markers for epithelial ovarian cancer with gene expression arrays and recursive descent partition analysis, Clin. Cancer Res., vol. 10, pp. 3291-3300, 2004.
24. A. Naderi, A. E. Teschendorff, N. L. Barbosa-Morais, S. E. Pinder, A. R. Green, D. G. Powe, J. F. R. Robertson, S. Aparicio, I. O. Ellis, J. D. Brenton, and C. Caldas, A gene-expression signature to predict survival in breast cancer across independent data sets, Oncogene, vol. 26, no. 10, pp. 1507-1516, 2007.
25. A. Yemelyanov, J. Czwornog, D. Chebotaev, A. Karseladze, E. Kulevitch, X. Yang, and I. Budunova, Tumor suppressor activity of glucocorticoid receptor in the prostate, Oncogene, vol. 26, no. 13, pp. 1885-1896, 2007. (Pubitemid 46474637)
26. R. P. Bourette, M.-F. Grasset, and G. Mouchiroud, E2a/Pbxl oncogene inhibits terminal differentiation but not myeloid potential of pro-T cells, Oncogene, vol. 26, no. 2, pp. 234-247, 2007.
27. J. S. Ross, P. Kaur, C. E. Sheehan, H. A. G. Fisher, R. A. Kaufman, and B. V. S. Kallakury, Prognostic significance of matrix metalloproteinase 2 and tissue inhibitor of metalloproteinase 2 expression in prostate cancer, Mod. Pathol., vol. 16, no. 3, pp. 198-205, 2003.
28. I. Watermann, J. Gerspach, M. Lehne, J. Seufert, B. Schneider, K. Pfizenmaier, and H. Wajant, Activation of CD95L fusion protein prodrugs by tumor-associated proteases, Cell Death Differ., vol. 14, pp. 765-74, 2007.
29. N. A. E. Teschendorff, N. L. Barbosa-Morais, S. E. Pinder, A. R. Green, D. G. Powe, J. F. R. Robertson, S. Aparicio, I. O. Ellis, J. D. Brenton, and C. Caldas, A gene-expression signature to predict survival in breast cancer across independent data sets, Oncogene, vol. 26, pp. 1507-1516, 2007.
30. S. Vanharanta, N. C Wortham, J. Arola, I. P. Tomlinson, A. Karhu, D. Arango, and L. A. Aaltonen, 7q deletion mapping and expression profiling in uterine fibroids, Oncogene, vol. 24, pp. 6545-6554, 2005.
31. R. Gianni-Barrera, M. Gariboldi, L. De Cecco, G. Manenti, and T. A. Dragani, Specific gene expression profiles distinguish among functional allelic variants of the mouse Pthlh gene in transfected human cancer cells, Oncogene, vol. 25, pp. 4501-4504, 2006.
32. P. Laiho, A. Kokko, S. Vanharanta, R. Salovaara, H. Sammalkorpi, T. J. Karttunen, K. Tuppurainen, V. Davalos, S. Schwartz, D. Arango, and L. A. Aaltonen, Serrated carcinomas form a subclass of colorectal cancer with distinct molecular basis, Oncogene, vol. 26, pp. 312-320, 2007.
33. F. K. Johansson and B. Westermark, Expression analysis of genes involved in brain tumor progression driven by retroviral insertional mutagenesis in mice, Oncogene, vol. 24, pp. 3896-3905, 2005.
34. M. Herzig, F. Savarese, M. Novatchkova, H. Semb, and G. Christofori, Tumor progression induced by the loss of E-cadherin independent of]-catenin/Tcf-mediated Wnt signaling, Oncogene, vol. 26, pp. 2290-2298, 2007.
35. W. Li, P. Kessler, and B. R G Williams, Transcript profiling of Wilms tumors reveals connections to kidney morphogenesis and expression patterns associated with anaplasia, Oncogene, vol. 24, pp. 457-468, 2005.
36. L. Bingle, V. Singleton, and C. D. Bingle, The putative ovarian tumour marker gene HE4 (WFDC2), is expressed in normal tissues and undergoes complex alternative splicing to yield multiple protein iso-forms, Oncogene, vol. 21, pp. 2768-2773, 2002.
37. C. Morales, M. Ribas, G. Aiza, and M. A. Peinado, Genetic determinants of methotrexate responsiveness and resistance in colon cancer cells, Oncogene, vol. 24, pp. 6842-6847, 2005.
38. I. Riz and R. G. Hawley, G1/S transcriptional networks modulated by the HOX11/TLX1 oncogene of T-cell acute lymphoblastic leukemia, Oncogene, vol. 24, pp. 5561-5575, 2005.
39. M. Jechlinger, S. Grunert, I. H. Tamir, E. Janda, T. Waerner, P. Seither, A. Weith, H. Beug, and N. Kraut, Expression profiling of epithelial plasticity in tumor progression, Oncogene, vol. 22, pp. 7155-7169, 2003.
40. Y.-M. Lin, Y. Furukawa, T. Tsunoda, C.-T. Yue, K.-C. Yang, and Y. Nakamura, Molecular diagnosis of colorectal tumors by expression profiles of 50 genes expressed differentially in adenomas and carcinomas, Oncogene, vol. 21, pp. 4120-4128, 2002.
41. A. L. Edwards, An Introduction to Linear Regression and Correlation, San Francisco, CA: W. H. Freeman, 1976.
42. C.-C. Chang and C.-J. Lin, LIBSVM: a library for support vector machines, 2001, software available at http://www.csie.ntu.edu.tw /cjlin/libsvm.
43. C. V. Ustach, M. E. Taube, N. J. Hurst Jr, S. Bhagat, R. D. Bonfil, M. L. Cher, L. Schuger, and H. R. Kim, A potential oncogenic activity of platelet-derived growth factor d in prostate cancer progression, Cancer Res., vol. 64, pp. 1722-1729, 2004.
44. A. R. Hanauske, Translational research with pemetrexed in breast cancer, Oncology, vol. 18, pp. 66-69, 2004.
45. M. Rodriguez, S. Coma, V. Noe, and C. J. Ciudad, Development and effects of immunoliposomes carrying an antisense oligonucleotide against DHFR RNA and directed toward human breast cancer cells overexpressing HER2, Antisense Nucleic Acid Drug Dev., vol. 12, pp. 311-325, 2002.
46. H. Hernandez-Vargas, S. M. Rodriguez-Pinilla, M. Julian-Tendero, P. Sanchez-Rovira, C. Cuevas, A. Anton, M. J. Rios, J. Palacios, and G. Moreno-Bueno, Gene expression profiling of breast cancer cells in response to gemcitabine: NF-kappaB pathway activation as a potential mechanism of resistance, Breast Cancer Res. Treat., vol. 102, pp. 157-172, 2007.
47. J. Yu, V. Baron, D. Mercola, T. Mustelin, and E. D. Adamson, A network of p73, p53 and Egrl is required for efficient apoptosis in tumor cells, Cell Death Differ., vol. 14, pp. 436-446, 2007.
48. N. Ilan, M. Elkin, and I. Vlodavsky, Regulation, function and clinical significance of heparanase in cancer metastasis and angiogenesis, Int. J. Biochem. Cell Biol., vol. 38, pp. 2018-2039, 2006. (Pubitemid 44397619)
49. M. Lucerna, J. Pomyje, D. Mechtcheriakova, A. Kadl, F. Gruber, M. Bilban, Y. Sobanov, G. Schabbauer, J. Breuss, O. Wagner, M. Bischoff, M. Clauss, B. R. Binder, and E. Hofer, Sustained expression of early growth response protein-1 blocks angiogenesis and tumor growth, Cancer Res., vol. 66, pp. 6708-6713, 2006.
50. K. Kraemer, U. Schmidt, S. Fuessel, A. Herr, M. P. Wirth, and A. Meye, Microarray analyses in bladder cancer cells: inhibition of hTERT expression down-regulates EGFR, Int. J. Cancer, vol. 119, pp. 1276-1284, 2006.
51. S. Z. Yang, I. A. Eltoum, and S. A. Abdulkadir, Enhanced EGR1 activity promotes the growth of prostate cancer cells in an androgen-depleted environment, J. Cell Biochem., vol. 97, pp. 1292-1299, 2006.
52. D. Juric, S. Sale, R. A. Hromas, R. Yu, Y. Wang, G. E. Duran, R. Tibshirani, L. H. Einhorn, and B. I. Sikic, Gene expression profiling differentiates germ cell tumors from other cancers and defines sub-type-specific signatures, Proc. Natl. Acad. Sci. USA, vol. 102, pp. 17763-17768, 2005.
53. M. Y. Wu, X. Y. Wu, Q. S. Li, and R. M. Zheng, Expression of Egr-1 gene and its correlation with the oncogene proteins in non-irradiated and irradiated esophageal squamous cell carcinoma, Dis. Esophagus, vol. 19, pp. 267-272, 2006.
54. K. H. Shin, M. K. Kang, R. H. Kim, R. Christensen, and N. H. Park, Heterogeneous nuclear ribonucleoprotein G shows tumor suppressive effect against oral squamous cell carcinoma cells, Clin. Cancer Res., vol. 12, pp. 3222-3228, 2006.
55. K. Singletary and A. Ellington, Genistein suppresses proliferation and MET oncogene expression and induces EGR-1 tumor suppressor expression in immortalized human breast epithelial cells, Anticancer Res., vol. 26, pp. 1039-1048, 2006.
56. S. Langer, C. F. Singer, G. Hudelist, B. Dampier, K. Kaserer, U. Vinatzer, H. Pehamberger, C. Zielinski, E. Kubista, and M. Schreibner, Jun. and Fos family protein expression in human breast cancer: Corre-lation of protein expression and clinicopathological parameters, Eur. J. Gynaecol Oncol., vol. 27, pp. 345-352, 2006.
57. R. Zenz and E. F. Wagner, Jun. signalling in the epidermis: From developmental defects to psoriasis and skin tumors, Int. J. Biochem. Cell Biol., vol. 38, pp. 1043-1049, 2006.
58. A. Marreiros, K. Dudgeon, V. Dao, M. O. Grimm, R. Czolij, M. Crossley, and P. Jackson, KAI1 promoter activity is dependent on p53, junB and AP2: evidence for a possible mechanism underlying loss of KAI1 expression in cancer cells, Oncogene, vol. 24, pp. 637-649, 2005.
59. G. Troen, V. Nygaard, T. K. Jenssen, I. M. Ikonomou, A. Tierens, E. Matutes, A. Gruszka-Westwood, D. Catovsky, O. Myklebost, G. Lauritzsen, E. Hovig, and J. Delabie, Constitutive expression of the AP-1 transcription factors c-jun, junD, junB, and c-fos and the marginal zone B-cell transcription factor Notch2 in splenic marginal zone lymphoma, J. Mol. Diagn., vol. 6, pp. 297-307, 2004.
60. N. Selvamurugan, S. Kwok, N. C. Partridge, Smad3 interacts with JunB and Cbfal/Runx2 for trans-forming growth factor-betal-stimulated collagenase-3 expression in human breast cancer cells, J. Biol. Chem., vol. 279, pp. 27764-27773, 2004.
61. X. Mao, G. Orchard, D. M. Lillington, R. Russell-Jones, B. D. Young, and S. J. Whittaker, Amplification and overexpression of JUNB is associated with primary cutaneous T-cell lymphomas, Blood, vol. 101, pp. 1513-1519, 2003.
62. S. G. Isler, C. U. Ludwig, R. Chiquet-Ehrismann, and S. Schenk, Evidence for transcriptional repression of SPARC-like 1, a gene downregulated in human lung tumors, Int. J. Oncol., vol. 25, pp. 1073-1079, 2004.
63. P. E. Framson and E. H. Sage, SPARC and tumor growth: Where the seed meets the soil?, J. Cell Biochem., vol. 92, pp. 679-690, 2004.
64. S. G. Isler, S. Schenk, I. Bendik, P. Schraml, H. Novotna, H. Moch, G. Sauter, and C. U. Ludwig, Genomic organization and chromosomal mapping of SPARC-like 1, a gene down regulated in cancers, Int. J. Oncol, vol. 18, pp. 521-526, 2001.
65. P. Schraml, R. Shipman, M. Colombi, and C. U. Ludwig, Identification of genes differentially expressed in normal lung and non-small cell lung carcinoma tissue, Cancer Res., vol. 54, pp. 5236-5240, 1994.
66. M. Fryknas, U. Wickenberg-Bolin, H. Goransson, M. G. Gustafsson, T. Foukakis, J. J. Lee, U. Landegren, A. Hoog, C. Larsson, L. Grimelius, G. Wallin, U. Pettersson, and A. Isaksson, Molecular markers for discrimination of benign and malignant follicular thyroid tumors, Tumor Biol, vol. 27, pp. 211-220, 2006.
67. R. Gianni-Barrera, M. Gariboldi, L. De Cecco, G. Manenti, and T. A. Dragani, Specific gene expression profiles distinguish among functional allelic variants of the mouse Pthlh gene in transfected human cancer cells, Oncogene, vol. 25, pp. 4501-4504, 2006.
68. J. Helleman, M. P. Jansen, P. N. Span, I. L. van Staveren, L. F. Massuger, M. E. Meijer-van Gelder, F. C. Sweep, P. C. Ewing, M. E. van der Burg, G. Stoter, K. Nooter, and E. M. Berns, Molecular profiling of platinum resistant ovarian cancer, Int. J. Cancer, vol. 118, pp. 1963-1971, 2006.
69. E. T. Ifon, A. L. Pang, W. Johnson, K. Cashman, S. Zimmerman, S. Muralidhar, W. Y. Chan, J. Casey, and L. J. Rosenthal, U94 alters FN1 and ANGPTL4 gene expression and inhibits tumorigenesis of prostate cancer cell line PC3, Cancer Cell Int., vol. 5, no. 19, 2005.
70. H. R. Abeysinghe, Q. Cao, J. Xu, S. Pollock, Y. Veyberman, N. L. Guckert, P. Keng, and N. Wang, THY1 expression is associated with tumor suppression of human ovarian cancer, Cancer Genet. Cytogenet., vol. 143, pp. 125-132, 2003.
71. T. R. Newton, P. G. Parsons, D. J. Lincoln, M. C. Cummings, D. K. Wyld, P. M. Webb, A. C. Green, and G. M. Boyle, Expression profiling correlates with treatment response in women with advanced serous epithelial ovarian cancer, Int. J. Cancer, vol. 119, pp. 875-883, 2006.
72. N. I. Fernandez-Garcia, H. G. Palmer, M. Garcia, A. Gonzalez-Martin, M. del Rio, D. Barettino, O. Volpert, A. Munoz, and B. Jimenez, 1alpha, 25-Dihydroxyvitamin D3 regulates the expression of Id1 and Id2 genes and the angiogenic phenotype of human colon carcinoma cells, Oncogene, vol. 24, pp. 6533-6544, 2005.
73. M. Stighall, C. Manetopoulos, H. Axelson, and G. Landberg, High ID2 protein expression correlates with a favourable prognosis in patients with primary breast cancer and reduces cellular invasiveness of breast cancer cells, Int. J. Cancer, vol. 115, pp. 403-411, 2005.
74. J. P. Coppe, Y. Itahana, D. H. Moore, J. L. Bennington, and P. Y. Desprez, Id-1 and Id-2 proteins as molecular markers for human prostate cancer progression, Clinical Cancer Res., vol. 10, pp. 2044-2051, 2004.
75. X. Xiao, M. Athanasiou, I. A. Sidorov, I. Horikawa, G. Cremona, D. Blair, J. C. Barret, and D. S. Dimitrov, Role of Ets/Id proteins for telomerase regulation in human cancer cells, Exp. Mol. Pathol, vol. 75, pp. 238-247, 2003.
76. J. Houldsworth, V. E. Reuter, G. J. Bosl, and R. S. Chaganti, ID gene expression varies with lineage during differentiation of pluripotential male germ cell tumor cell lines, Cell Tissue Res., vol. 303, pp. 371-379, 2001.
77. B. Eickhoff, S. Ruller, T. Laue, G. Kohler, C. Stahl, M. Schlaak, and J. van der Bosch, T Trichostatin A modulates expression of p21wafl/cipl, Bcl-xL, ID1, ID2, ID3, CRAB2, GATA-2, hsp86 and TFIID/TAFII31 mRNA in human lung adenocarcinoma cells, Biol. Chem., vol. 381, pp. 107-112, 2000.
78. J. Kleeff, T. Ishiwata, H. Friess, M. W. Buchler, M. A. Israel, and M. Korc, The helix-loop-helix protein Id2 is overexpressed in human pancreatic cancer, Cancer Res., vol. 58, pp. 3769-3772, 1998.
79. A. Ishiguro, K. S. Spirin, M. Shiohara, A. Tobler, A. F. Gombart, M. A. Israel, J. D. Norton, and H. P. Koeffler, Id2 expression increases with differentiation of human myeloid cells, Blood, vol. 87, pp. 5225-5231, 1996. (Pubitemid 26189865)
80. L. W. Cheung, P. C. Leung, and A. S. Wong, Gonadotropin-releasing hormone promotes ovarian cancer cell invasiveness through c-Jun. NH2-terminal kinase-mediated activation of matrix metalloproteinase (MMP) -2 and MMP-9, Cancer Res., vol. 66, pp. 10902-10910, 2006.
81. A. Harder, V. F. Mautner, R. E. Friedrich, T. Harder, A. Plagemann, and A. von Deimling, Transcription factor AP-2 is expressed in human Schwann cell-derived tumours, Histopathology, vol. 49, pp. 441-443, 2006.
82. H. Li, P. C. Goswami, and F. E. Domann, AP-2gamma induces p21 expression, arrests cell cycle, and inhibits the tumor growth of human carcinoma cells, Neoplasia, vol. 8, pp. 568-577, 2006.
83. S. M. Hong, H. F. Frierson, and C. A. Moskaluk, AP-2gamma protein expression in intratubular germ cell neoplasia of testis, Am. J. Clin. Pathol., vol. 124, pp. 873-877, 2005.
84. E. Odegaard, A. C. Staff, J. Kaern, V. A. Florenes, J. Kopolovic, C. G. Trope, V. M. Abeler, R. Reich, and B. Davidson, The AP-2gamma transcription factor is upregulated in advanced-stage ovarian car-cinoma, gynecol, Oncol., vol. 100, pp. 462-468, 2006.
85. K. Pauls, R. Jager, S. Weber, E. Wardelmann, A. Koch, R. Buttner, and H. Schorle, Transcription factor AP-2gamma, a novel marker of gonocytes and seminomatous germ cell tumors, Int. J. Cancer, vol. 115, pp. 470-477, 2005.
86. A. Marreiros, K. Dudgeon, V. Dao, M. O. Grimm, R. Czolij, M. Crossley, and P. Jackson, KAI1 promoter activity is dependent on p53, junB and AP2: evidence for a possible mechanism underlying loss of KAI1 expression in cancer cells, Oncogene, vol. 24, pp. 637-649, 2005.
87. J. Okamoto, M. Onda, T. Hirata, S. Miyamoto, J. Akaishi, I. Mikami, K. Hirai, S. Haraguchi, K. Koizumi, and K. Shimizu, Dissimilarity in gene expression profiles of lung adenocarcinoma in Japanese men and women, Gender Medicine, vol. 3, pp. 223-235, 2006.
88. M. T. Galgano, G. M. Hampton, and H. F. Frierson, Comprehensive analysis of HE4 expression in normal and malignant human tissues, Modern Pathology, vol. 19, pp. 847-853, 2006.
89. L. Bingle, S. S. Cross, A. S. High, W. A. Wallace, D. Rassl, G. Yuan, I. Hellstrom, M. A. Campos, and C. D. Bingle, WFDC2 (HE4) : A potential role in the innate immunity of the oral cavity and respiratory tract and the development of adenocarcinomas of the lung, Respiratory Research, vol. 7, no. 61, pp. 1465-9921, 2006.
90. D. G. Peters, D. M. Kudla, J. A. Deloia, T. J. Chu, L. Fairfull, R. P. Edwards, and R. E. Ferrell, Comparative gene expression analysis of ovarian carcinoma and normal ovarian epithelium by serial analysis of gene expression, Cancer Epidem. Biomar., vol. 14, pp. 1717-1723, 2005.
91. I. Hellstrom, J. Raycraft, M. Hayden-Ledbetter, J. A. Ledbetter, M. Schummer, M. Mcintosh, C. Drescher, N. Urban, and K. E Hellstrom, The HE4 (WFDC2) protein is a biomarker for ovarian carcinoma, Cancer Res., vol. 63, pp. 3695-3700, 2003.
92. L. Bingle, V. Singleton, and C. D. Bingle, The putative ovarian tumour marker gene HE4 (WFDC2), is expressed in normal tissues and undergoes complex alternative splicing to yield multiple protein iso-forms, Oncogene, vol. 21, pp. 2768-2773, 2002.
93. KEGG: Kyoto Encyclopedia of Genes and Genomes, 2007, available at http://www.genome.jp/kegg/.